Genetic Study of Lupus Patients and Their Families
Recruitment status was Recruiting
The purpose of this study is to perform genetic testing in and to collect information from families affected by lupus in order to identify the genetic factors associated with systemic lupus erythematosus (SLE).
Systemic Lupus Erythematosus
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Gene Mapping in Women With SLE|
|Study Start Date:||July 1996|
|Estimated Study Completion Date:||June 2011|
|Estimated Primary Completion Date:||June 2011 (Final data collection date for primary outcome measure)|
Unaffected family members of SLE patients
Little is known about the genetic factors that predispose people to developing SLE. Genes in patients with SLE may provide clues about SLE's pathogenesis. This study will compare genes from SLE patients, their unaffected family members, and control participants. Travel to the study site is not required.
In this study, blood samples will be collected from people diagnosed with SLE, their unaffected family members, and condition-matched controls. Participants will be asked questions about their health and will provide a small blood sample. Participants will also be asked to provide written permission for release of medical information, so that their disease status can be verified through medical record review or through consultation with their doctors. Study personnel may contact participants in the future for follow-up questions and additional blood draws, if the participant agrees.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00235378
|Contact: Angie Simonsonfirstname.lastname@example.org|
|United States, Minnesota|
|University of Minnesota||Recruiting|
|Minneapolis, Minnesota, United States, 55455|
|Contact: Angie Simonson 800-515-8787 email@example.com|
|Principal Investigator: Timothy W. Behrens, MD|
|Principal Investigator:||Timothy W. Behrens, MD||University of Minnesota - Clinical and Translational Science Institute|
|Principal Investigator:||Patrick Gaffney||University of Minnesota - Clinical and Translational Science Institute|